Insulin glargine and lixisenatide and Onasemnogene abeparvovec Zolgensma
Determining the interaction of Insulin glargine and lixisenatide and Onasemnogene abeparvovec Zolgensma and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: onasemnogene abeparvovec
Brand name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma), Onasemnogene Abeparvovec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Oncaspar
- Insulin glargine and lixisenatide-Oncovin
- Insulin glargine and lixisenatide-Ondansetron
- Insulin glargine and lixisenatide-Ondansetron and Dextrose
- Insulin glargine and lixisenatide-Ondansetron Hydrochloride
- Insulin glargine and lixisenatide-Ondansetron injection
- Onasemnogene abeparvovec Zolgensma-Insulin glargine and lixisenatide Subcutaneous
- Onasemnogene abeparvovec Zolgensma-Insulin glargine, recombinant Subcutaneous
- Onasemnogene abeparvovec Zolgensma-Insulin glulisine
- Onasemnogene abeparvovec Zolgensma-Insulin Glulisine (Cartridges and Pens)
- Onasemnogene abeparvovec Zolgensma-Insulin Glulisine (Vials)
- Onasemnogene abeparvovec Zolgensma-Insulin glulisine Subcutaneous